LT-related inducible ligand that competes for glycoprotein D binding to herpesvirus entry mediator on T cells (LIGHT) is a recently cloned type II transmembrane protein belonging to the TNF family that was originally identified as a weak inducer of apoptosis. This cytokine has been extensively defined in its role on T-cell regulation and dendritic cell maturation. However, whether this cytokine regulates stem cell proliferation and/or differentiation remains unknown. In this study, we transduced exogenous LIGHT into embryonic stem cells (ES cells) and found it induced their differentiation. The expression of phospho-STAT3, Nanog and Oct-4 was reduced in LIGHT-transduced ES cells compared with wild-type ES cells. LIGHT-transduced ES cells exhibit a low level of SSEA-1 surface antigen and alkaline phosphatase staining compared with wild-type cells. Introduction of LIGHT into ES cells results in the dephosphorylation of MKP-3 and activation of extracellular signal-regulated kinase (ERK)5. When ERK5 was inhibited by the specific inhibitor PD184352 or knocked down by ERK5 siRNA, reduction of Oct-4 and SSEA-1 expression was rescued. We conclude that LIGHT overrides leukemia inhibitory factor to induce ES cell differentiation associated with activation of ERK5.
Introduction
Embryonic stem (ES) cells are primitive, undifferentiated cells from the embryo that have the potential to become a wide variety of specialized cell types. Mouse ES cells are derived from the inner cell mass of the 3.5-day-old blastocyst (Evans and Kaufman, 1981) . The cells of the inner cell mass are pluripotent and differentiate into multiple cell lineages of the embryo. ES cells retain the differentiation ability of the inner cell mass after many passages (Sato and Nakano, 2001) . ES cells are originally maintained on feeder layers of mouse embryonic fibroblasts (Evans and Kaufman, 1981) . Subsequently, leukemia inhibitory factor (LIF) was identified as a key factor in maintaining immaturity; that is, pluripotent differentiation ability (Williams et al., 1988) . ES cells are able to differentiate to embryonic bodies in the absence of LIF in the culture, which contains multiple kinds of stem cells.
Cytokines of TNF family member regulate various cellular responses, including proliferation, migration, inflammation, and cell death. For example, TWEAK has been reported to induce proliferation and migration of human umbilical vein endothelial cells (HUVEC) in vitro (Lynch et al., 1999; Wiley et al., 2001) . On ES cells, TNF-a inhibits their differentiation (Wuu et al., 1998) . LT-related inducible ligand that competes for glycoprotein D binding to herpesvirus entry mediator on T cells (LIGHT) is a recently cloned type II transmembrane protein belonging to the TNF family that was originally identified as a weak inducer of apoptosis. (Mauri et al., 1998) . It could induce both apoptotic and nonapoptotic events in the cells. Normally, caspase signal transduction is involved in apoptosis mediated by LIGHT. LIGHT mRNA was not detected in the embryonic tissue, raising the possibility that it may not function during lymph-node genesis (Mauri et al., 1998) . This cytokine has been extensively defined in its role on T-cell regulation. Our previous report demonstrated that LIGHT could induce monocyte differentiation toward dendritic cells (Zou et al., 2004) . However, the question regarding whether this cytokine regulates stem cell proliferation and or differentiation remains unknown.
Extracellular signal-regulated kinase (ERK)1 and ERK2 activation is associated with inhibition of selfrenewal and promotes differentiation in ES cells. ERK5 is an atypical MAPK that is also known as Big mitogenactivated protein kinase 1 (BMK1) (Hayashi et al., 2004) . This kinase is required for cell proliferation induced by EGF in Hela cells (Kato et al., 1998) . It can be activated by mitogen-activated protein kinase kinase 5 (MEK5) (Mody et al., 2003) . Mouse embryos lacking ERK5 exhibited retarded growth and vascular defects in the yolk sacs (Sohn et al., 2002) . This indicates that ERK5 might be involved in stem cell development. LIF slightly activates ERK5 through gp130 on neonatal rat cardiomyocytes (Nakaoka et al., 2003) . However, whether ERK5 is involved in the maintenance of pluripotency of ES cells remains unknown currently.
To address the question of whether it inhibits ES cell differentiation as in TNF-a, we transduced exogenous LIGHT into ES cells. To our surprise, unlike TNF-a, we found that LIGHT promotes ES cell differentiation and can override the role of LIF in maintaining pluripotency of ES cells. The stage-specific embryonic antigen-1 (SSEA-1) is used as a specific marker of undifferentiated ES cells because cells lose SSEA-1 expression when they differentiate (Smith et al., 1988) . Nanog is a newly found homeodomain gene encoding polypeptide of 305 residues with a divergent homeodomain similar to those in the NK-2 family (Wu and Yao, 2005) . It is expressed in undifferentiated ES cells but disappeares in differentiated ES cells (Chambers et al., 2003) . Oct-4 is a transcription factor belonging to POU transcription factor family. It seems Oct-4 is exclusively expressed in ES cells with expression reduced or negative following ES cell commitment to differentiation (Pan et al., 2002) . The ES cells transduced with LIGHT express low level of phosphor-STAT3, Nanog, Oct-4 and SSEA-1. LIGHT transduced ES cells also exhibited higher activation of ERK5. This study then reveals a novel phenomenon of LIGHT in regulation of embryonic stem cell differentiation associated with enhanced ERK5 activation.
Results

Stable expression of LIGHT on ES cells induces their differentiation
Wild-type ES cell did not express LIGHT. LIGHT was detectable by Western blot in LIGHT-transfected ES cells but not the cells transfected with empty vector (Figure 1a ). Both flow cytometry and Western blot analysis showed that ES cells express Lymphoid toxin-b (LT-b) receptor but not Herpes virus entry mediator (HVEM) on their surface (Figure 1b, c) . Introduction of exogenous LIGHT into ES cells caused their differentiation as assessed by ES cell clone morphology ( Figure 2a ) and SSEA-1 expression detected by flow cytometry (Figure 2b ). SSEA-1 expression has been decreased over 40% in LIGHT-transfected ES cells compared with the cells transfected with empty vector. Staining with Leishman's reagent revealed that over 50% of colonies were differentiated (Figure 2c ).
LIGHT impairs ES cell-derived embryoid body propagation
Embryoid body (EB) formation occurs through asymmetric division of single ES cells. We found that LIGHT-transfected ES cells partly lose cell division potential as seen by the reduced size of formed EB (Figure 3a) . Moreover, LIGHT-transduced ES cells showed a significant reduction in frequency of EB formation (Figure 3b ).
LIGHT promotes ES cell differentiation
We examined SSEA expression on LIGHT-transfected ES cells by flow cytometry. As shown in Figure 2b , SSEA-1 antigen expression on LIGHT-transfected cells is lower compared with the cells transfected with empty vector. We then also examined Oct-4 and Nanog expression on these cells and show that both Oct-4 and Nanog protein expression were reduced in LIGHTtransfected ES cells compared with cells transfected with control empty vector (Figure 4a ). By immunocytochemistry staining assay, the ALP positive rate in LIGHTtransduced ES cells was obviously decreased compared with control cells transfected with empty vector (Figure 4b ).
LIGHT inhibits tyrosine phosphorylation but induces serine phosphorylation of STAT3 on ES cells
ES cells both transfected with empty vector or LIGHT vector were cultured with LIF. LIF could stimulate tyrosine phosphorylation of STAT3 and render it active. In contrast, LIGHT could inhibit STAT3 tyrosine phosphorylation, but induce its serine phosphorylation ( Figure 5 ). 
MAPK is activated in LIGHT-transfected ES cells
ERK1/2 was activated on ES cells by LIGHT ( Figure 6 ), but JNK and p38MAPK were remained inactive (data not shown). Moreover, in a serum starvation experiment, the results were consistent with the cells cultured with 10% FCS. Phospho-ERK5 was slightly expressed in wild-type ES cells. In contrast, ES cells transfected with LIGHT expressed a higher level of phospho-ERK5.
LIGHT inhibits MKP-3 activation on ES cells
MAP kinase phosphatase-3 (MKP-3) activation was reduced when ES cells were transfected with LIGHT plasmid. Western blot examination was performed for ES cells transfected with either empty vector or LIGHT plasmid. The results demonstrated that phospho-MKP-3 was reduced when cells were transfected with LIGHT ( Figure 6a ). There was no difference in the phospho-MKP-1 protein between ES cells transfected with either empty vector or LIGHT detected by Western blot (Figure 6a ).
Inhibition of ERK5, but not ERK1/2 signaling prevents sLIGHT-induced ES cell differentiation
LIGHT did not activate JNK but activated ERK1/2 in dendritic cells in our previous work (Zou and Hu, 2005) . In this study, we found that ERK1/2, and ERK5 were activated on ES cells by LIGHT (Figure 6b ). Soluble LIGHT (sLIGHT) overrides the role of LIF in ES cell differentiation inhibition and induces their differentiation as marked by reduction of SSEA-1 and Oct-4 expression on these cells. (Figure 7 ). Simple inhibition of ERK1/2 by PD98059 could not rescue the reduction of SSEA-1 and Oct-4 expression induced by sLIGHT. In contrast, when ERK5 was inhibited by PD184352, reduction of Oct-4 expression was rescued. As PD184352 also inhibits ERK1/2 as well as ERK5, we then used ERK1 or ERK5 small interfering RNA (siRNA) to specifically knockdown ERK1 or ERK5 expression. As shown in Figure 7c , knockdown of ERK5, but not ERK1 blocked the role of LIGHT in decreasing Oct-4 expression.
Discussion
LIGHT is a recently cloned novel cytokine belonging to TNF family (Mauri et al., 1998) . A soluble, secreted form of LIGHT stimulates proliferation of T lymphocytes during allogenic response. This was defined as a three-way mixed lymphocyte reaction in which three donor cells are mixed together, and the resulting allogenic proliferation was measured (Harrop et al., 1998) . This cytokine has also been described in its role of regulation of dendritic cell activity (Morel et al., 2001; Zou et al., 2004; Zou and Hu, 2005) . However, the role of this cytokine on stem cell regulation has been less reported. In this study, we first offered evidence that it is also involved in the regulation of stem cells. The primary objective of the present study was to try to examine the role of LIGHT in regulation of stem cell function, such as self-renewal, differentiation or apoptosis. In this study, we demonstrated LIGHT promoted ES cell differentiation through activation of ERK5. According to our knowledge, this is the first evidence to show that LIGHT, a novel cytokine of TNF family, has a direct role in regulation of embryonic stem cells. It has been well accepted that mouse ES cells remain pluripotent status without differentiation in vitro in the presence of LIF. When LIF is removed, ES cells are irreversibly committed to differentiation into various lineages (Boeuf et al., 2001) . The cytokines of TNF family play multiple roles in regulation of ES cells. TNF-a could inhibit IL-6-mediated STAT3 activation in RAW264.7 cells (Bode et al., 2003) . Whether TNF-a also inhibits LIF-mediated STAT3 activation in ES cells has yet to be defined, though ES cells transfected with TNF-a plasmid enhanced their migration activities (Chen et al., 2003) . When ES cells were maintained with LIF, addition of TNF-a in culture could not override the negative control exerted by LIF on differentiation; when ES cells were cultured without LIF, TNF-a decreased the ability of ES cells to differentiate into EBs (Wuu et al., 1998) . However, in this study, we identified a novel phenomenon that LIGHT overrides the role of LIF in maintenance of pluripotency of ES cells. Transduction of exogenous LIGHT into ES cells did not induce their apoptosis (data not shown). FasL is also a member of TNF family (Zou et al., 2000) . Our previous study revealed that crosslinking Fas antigen on ES cell surface by anti-Fas antibody triggered apoptosis on these cells (Zou et al., 2000) . However, recent reports indicated another interesting phenomenon: FasL expressed on ES cells may play a critical role in ES cells-mediated immune privilege (Fandrich et al., 2002) . We once hypothesized that transduction of LIGHT into ES cells might increase their potential in immune tolerance induction in organ transplantation through secreting LIGHT to induce apoptosis of cytotoxic T cells (Zou and Zavazava, 2003b) . However, in this study, we found the unexpected result that LIGHT-induced ES cells differentiation in vitro.
When ES cells are maintained with LIF, they multiply by symmetrical cell division, and routinely expanded to give relatively homogenous and undifferentiated population. LIF signaling through STAT3 and the appro- priate expression of Oct-4 is well-established for the maintenance of the pluripotent, undifferentiated state of mouse ES cells (Smith, 2001 ). LIF could phosphorylate STAT3 both in tyrosine residue 705 and serine residue 727. Both P-Y-705-STAT3 and P-S-727-STAT3 had similar levels probed by Western blot in ES cells (Boeuf et al., 2001 ). This might indicate that an optimal ratio between serine and tyrosine phosphorylation is a key condition to keep ES cell pluripotency. In this study, we found that introducing LIGHT into ES cells could break this balance by downregulating P-Y-705-STAT3, and upregulating P-S-727-STAT3 levels. We postulate serine phosphorylation on STAT3 suppresses its activation on ES cells, subsequently, leading to ES cells committing to differentiation. Although we found here that P-S-STAT3 level was increased in LIGHT-transfected ES cells, we have yet to rule out whether STAT3 is a direct substrate of ERK5 for serine phosphorylation.
ERK5 activation was negatively regulated by MKP-3 through dephosphorylation (Kamakura et al., 1999) . Both ERK5 and phospho-ERK5 were detectable by Western blot in day 3.5 proimplantation embryo (Wang et al., 2004) . The role of ERK5 in stem cell regulation, especially in stem cell differentiation has been poorly defined. In cardiomyocytes, LIF activated ERK5 caused longitudinal elongation of these cells (Nakaoka et al., 2003) . In this study, we found that LIF-maintained ES cells actually have a low level of phospho-ERK5 expression. However, LIGHT-transfected ES cells have increased phosphor-ERK5 expression, and inhibition of ERK5 by a specific inhibitor rescued ES cells from LIGHT-mediated differentiation. This indicates that ERK5 signaling is required in LIGHT-mediated ES cell differentiation.
We previously demonstrated that ES cells express Fas antigen on their surfaces (Zou et al., 2000) . In this study, we described that ES cells also express LT-bR but not HVEM on their surfaces. In humans, LIGHT can crosslink with either HVEM or LT-bR. As murine ES cells described in our study did not express HVEM, this suggests that LIGHT might induce ES cell differentiation through crosslinking with LT-bR.
In conclusion, this study shows the evidence that LIGHT promotes ES cell differentiation and ERK5 is associated in this course. Further study of this novel cytokine in regulation of other stem cells, such as neuronal stem cells, normal hematopoietic stem cells or leukemia stem cells would be worthwhile.
Materials and methods
Cell culture
The D3 ES cells were purchased from ATCC (passage number 9). Mouse D3 ES cells were maintained on gelatinized tissue culture dishes (100 mm; Costar, Cambridge, MA, USA) in standard ES culture medium consisting of Dulbecco's modified Eagle's medium (DMEM) supplemented with 15% fetal calf serum (FCS; GIBCO, Grand Island, NY, USA), 0.1 mmol Lglutamine, 150 mmol monothioglycerol (MTG), 100 U/ml penicillin, 100 mg/ml streptomycin, and 1000 U/ml LIF (Stem Cell Inc., Vancouver, Canada). The culture medium was changed every day, and the cells were passaged every 2 or 3 days (Zou et al., 2000) . L138.8A, a mouse mast cell line, was cultured in IMDM (Invitrogen, Carlsbad, CA, USA), 10% FCS, 100 U/ml penicillin, 100 mg/ml streptomycin, 20 U/ml IL-3.
Transfection of LIGHT expression plasmid to ES cells
The plasmid vector of full length of LIGHT cDNA was constructed as described (Tamada et al., 2000) . 1 Â 10 6 ES cells were transfected using 5 mg empty vector or LIGHT vector. Cells were cultured with LIF medium for 2 days. These cells were then treated by G418 at concentration of 750 mg/ml for 1 week for selection of a resistant clone. A G418-resistant clone was picked for expansion culture.
ES cell self-renewal assay ES cell self-renewal assay was performed to measure cloning identity (Niwa et al., 1998) . In summary, cells were plated at 100 cells per well (B100 cells/cm 2 ) in six-well dishes and cultured for 6 days. Cells were grown either in the absence of cytokine or in 100 U/ml LIF. On day 6, the colonies were fixed and stained with Leishman's reagent. Numbers of ES and differentiated colonies were scored by microscope examination. All assays were performed in triplicate.
Alkaline phosphatase staining
ES cells both transfected with empty vector or LIGHT vector were cultured for 5 days under LIF-containing ES maintaining culture medium and stained with the ALP substrate kit (Vector laboratories, Burlingame, CA, USA).
Flow cytometry analysis
Cell surface staining involved direct immunofluorescence (FACScan; Becton Dickinson, Mountain View, CA, USA), and the samples were analysed using Cell Quest software (Becton Dickinson, Mountain View, CA, USA). Staining was performed with the following FITC-conjugated isotype control antibody, SSEA-1 mAb (Santa Cruz Biotechnologies, Santa Cruz, CA, USA) or LT-b receptor antibody (Serotec Inc., Oxford, UK). The cells were washed and resuspended in PBS then read by flow cytometry. To perform HVEM expression analysis, the cells were stained with rat-antimouse HVEM antibody (R&D Systems, Minneapolis, MN, USA), then stained with appropriate FITC conjugate secondary antibody and analysed using FACScan analyzer.
Western blot analysis
Anti-mouse Oct-4, STAT3, P-Y-705-STAT3, P-S-STAT3, ERK1/2, ERK5, phospho-ERK5, Actin, and Tubulin antibodies were purchased from Santa Cruz Biotechnologies (Santa Cruz, CA, USA). Rabbit antimouse Nanog antibody was purchased from Kamiya Biomedical Co (Seattle, WA). Whole-cell protein extracts were prepared from both empty vector and LIGHT-transfected ES cells. A volume of 50 mg of protein was separated by SDS-polyacrylamide electrophoresis using a 10% (w/v) acrylamide resolving gel and transferred electrophoretically to a nitro-cellulose membrane. The blots were blocked with 5% TBS/T buffer for 1 h. Immunobloting was performed using the specific antibodies as recommended by manufacturers. All immunoblots were visualized by ECL (Amersham Pharmacia Biotech, Piscataway, NJ, USA).
Treatment of wild-type ES cell with soluble recombinant murine LIGHT
Recombinant mouse LIGHT (mLIGHT) was purchased from R&D Inc. (Minneapolis, MN, USA). ES cells were treated with BSA (10 ng/ml) as control or LIGHT (10 ng/ml). After 48 h of culture, cells were harvested for both flow cytometry to examine SSEA-1 expression on cell surface and Western blot to examine intracellular Oct-4 expression. In some groups, ERK1/2 inhibitor PD98059 (10 mM; New England Biolabs inc, Beverly, MA, USA) and ERK1/2/5 inhibitor PD184352 (10 mM; Upstate Biotechnology, Lake Placid, NY, USA) were added in the culture.
siRNA transfection
Refer to our previous work (Zou et al., 2003a) . In brief, ES cells were transferred to a 12-well plate with 1 Â 10 5 cells/well and cultured with LIF containing medium. Transfection of siRNA was carried out using Oligofectamine (Invitrogen, Carlsbad, CA, USA). The cells were separately transfected with control, ERK1 or ERK5 siRNA (Santa Cruz Biotechnologies, Santa Cruz, CA, USA) at 20 nM of final concentration.
After 24 h of transfection, sLIGHT (10 ng/ml) was added and the cells were cultured for another 48 h. Cells were then harvested for Western blot to examine Oct-4 expression.
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